Attribute COVAX and EU Joint Action Proposals Benefit-Based Advanced Market Commitment
Incentivise private capital to invest in developmentNo—push is needed Yes—and can be combined with existing push initiatives
Incentivise private capital to invest in manufacturingNo—push is needed Yes—but would need to be combined with separate push
Bilateral Contingent Advance Purchase contractsYesNo
Advance Market CommitmentPossibly in COVAX second stageYes
Incentivise follow-on vaccinesOnly if advance market commitment is put in placeYes—a major objective is to have more than one vaccine
Value-based pricingNoYes